Wells Fargo & Company Applied Therapeutics Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 35,736 shares of APLT stock, worth $344,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,736

Previous 35,296 1.25%

Holding current value

$344,137

Previous $164,000 84.76%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.35 - $8.5 $1,913 - $3,740	440 Added 1.25%	35,736 $303,000
Q2 2024 Aug 13, 2024	BUY	$4.04 - $6.37 $140,838 - $222,064	34,861 Added 8014.02%	35,296 $164,000
Q1 2024 May 10, 2024	BUY	$2.25 - $7.4 $15 - $51	7 Added 1.64%	435 $2,000
Q4 2023 Feb 09, 2024	SELL	$1.84 - $3.35 $139 - $254	-76 Reduced 15.08%	428 $1,000
Q3 2023 Nov 13, 2023	BUY	$1.26 - $2.77 $204 - $448	162 Added 47.37%	504 $1,000
Q2 2023 Aug 15, 2023	BUY	$0.77 - $1.8 $53 - $124	69 Added 25.27%	342 $0
Q1 2023 May 12, 2023	BUY	$0.75 - $1.21 $3 - $6	5 Added 1.87%	273 $0
Q4 2022 Feb 13, 2023	BUY	$0.54 - $1.12 $3 - $7	7 Added 2.68%	268 $0
Q3 2022 Nov 14, 2022	BUY	$0.86 - $1.55 $122 - $220	142 Added 119.33%	261 $0
Q2 2022 Aug 12, 2022	SELL	$0.76 - $2.64 $1,022 - $3,553	-1,346 Reduced 91.88%	119 $0
Q1 2022 May 16, 2022	SELL	$1.48 - $6.22 $9,257 - $38,906	-6,255 Reduced 81.02%	1,465 $3,000
Q4 2021 Feb 14, 2022	BUY	$8.77 - $18.29 $67,686 - $141,162	7,718 Added 385900.0%	7,720 $69,000
Q2 2021 Aug 16, 2021	SELL	$14.05 - $25.04 $33,846 - $60,321	-2,409 Reduced 99.92%	2 $0
Q1 2021 May 13, 2021	SELL	$16.57 - $28.65 $122,187 - $211,265	-7,374 Reduced 75.36%	2,411 $45,000
Q4 2020 Feb 09, 2021	BUY	$15.44 - $24.23 $5,203 - $8,165	337 Added 3.57%	9,785 $215,000
Q3 2020 Nov 05, 2020	SELL	$19.43 - $35.36 $48,302 - $87,904	-2,486 Reduced 20.83%	9,448 $196,000
Q2 2020 Aug 13, 2020	BUY	$29.41 - $51.23 $195,782 - $341,038	6,657 Added 126.15%	11,934 $432,000
Q1 2020 May 14, 2020	BUY	$19.54 - $55.47 $103,112 - $292,715	5,277 New	5,277 $172,000

Others Institutions Holding APLT

# of Institutions

140

Shares Held

112M

Call Options Held

1.68M

Put Options Held

1.91M

View Full List

About Applied Therapeutics Inc.

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $462M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

More about APLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Applied Therapeutics Inc. Transaction History